Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ACADIA Pharmaceuticals Inc. (ACAD)

43.43   -1.13 (-2.54%) 01-17 16:00
Open: 44.93 Pre. Close: 44.56
High: 45.17 Low: 42.91
Volume: 849,595 Market Cap: 6689M
ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson's, Alzheimer's and schizophrenia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 45.189 - 45.493 45.493 - 45.745
Low: 42.344 - 42.631 42.631 - 42.87
Close: 43.006 - 43.476 43.476 - 43.866

Technical analysis

as of: 2020-01-17 4:33:35 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 55.15     One year: 64.42
Support: Support1: 42.34    Support2: 39.32
Resistance: Resistance1: 47.22    Resistance2: 55.15
Pivot: 43.39
Moving Average: MA(5): 43.85     MA(20): 43.74
MA(100): 41.57     MA(250): 32.02
MACD: MACD(12,26): -0.19     Signal(9): -0.33
Stochastic oscillator: %K(14,3): 65.11     %D(3): 62.97
RSI: RSI(14): 47.95
52-week: High: 53.70  Low: 20.12  Change(%): 113.7
Average Vol(K): 3-Month: 155764  10-Days: 162848

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACAD has closed below upper band by 49.3%. Bollinger Bands are 33.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2020-01-07
ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2020, at 10:00 a.m. Pacific Time, followed by a question and answer breakout session. A live webcast of ACADIA’s presentation

2019-12-23
Has ACADIA Pharmaceuticals (ACAD) Outpaced Other Medical Stocks This Year?
Is (ACAD) Outperforming Other Medical Stocks This Year?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 154.02
Shares Float (M) 112.89
% Held by Insiders 0.09
% Held by Institutions 95.46
Shares Short (K) 10670
Shares Short P. Month (K)

Stock Financials

EPS -1.750
Book Value (p.s.) 4.490
PEG Ratio -0.96
Profit Margin -82.48
Operating Margin -85.71
Return on Assets (ttm) -31.2
Return on Equity (ttm) -54.3
Qtrly Rev. Growth 62.2
Gross Profit (p.s.) 0.119
Sales Per Share
EBITDA (p.s.) -1.652
Qtrly Earnings Growth
Operating Cash Flow (M) -160.50
Levered Free Cash Flow (M) -73.02

Stock Valuations

P/E -24.82
P/E Growth Ratio -0.03
P/BV 9.67
P/S 20.48
P/CF -41.68

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.